High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial.

Hermanides, R S; Heestermans, A A C M; Ten Berg, J M; Gosselink, A T M; Ottervanger, J P; van Houwelingen, K G; Kolkman, J J E; Stella, P R; Dill, T; Hamm, C; van 't Hof, A W J

Hermanides, R S; Heestermans, A A C M; Ten Berg, J M; Gosselink, A T M; Ottervanger, J P; van Houwelingen, K G; Kolkman, J J E; Stella, P R; Dill, T; Hamm, C; van 't Hof, A W J.

Affiliation

Hermanides RS; Isala Klinieken, Zwolle, The Netherlands.

Heart ; 97(2): 106-11, 2011 Jan.

Article in En | MEDLINE | ID: mdl-20962338

Subject(s)

Myocardial Infarction/drug therapy; Platelet Aggregation Inhibitors/administration & dosage; Tyrosine/analogs & derivatives; Angioplasty, Balloon, Coronary/methods; Double-Blind Method; Emergency Medical Services; Female; Humans; Male; Middle Aged; Preoperative Care/methods; Tirofiban; Treatment Outcome; Tyrosine/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine / Platelet Aggregation Inhibitors / Myocardial Infarction Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Heart Journal subject: CARDIOLOGIA Year: 2011 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google